Tanaka, Michio
Yamamoto, Tatsuo https://orcid.org/0000-0001-5147-3711
Kuribayashi, Nobuichi
Okuguchi, Fuminobu
Isotani, Haruhiko
Iwamoto, Masahiro
Sugimoto, Hidekatsu
Nakagawa, Osamu
Suzuki, Daisuke
Abe, Katsushige
Watanabe, Nobuaki
Minabe, Masato
Fuchida, Shinya
Yokoyama, Hiroki
Funding for this research was provided by:
8020 Promotion Foundation (18-6-16)
Article History
Received: 6 August 2019
Accepted: 30 September 2019
First Online: 16 October 2019
Compliance with ethical standards
:
: Kuribayashi received lecture fees from Mitsubishi Tanabe Pharma Corp. All other authors declare that they have no conflict of interest.
: The study protocol was approved by the ethics committees of Jiyugaoka Medical Clinic (October 27, 2014, No. 250716) and Kanagawa Dental University July 5, 2016, No. 387; September 12, 2017, No. 446; December 20, 2017, No. 476). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and/or with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.